Cargando…
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination
Recombinant adeno-associated virus (rAAV) shows great promise for gene therapy, however scalability, yield and quality remain significant issues. Here we describe an rAAV manufacturing strategy using a ‘helper’ adenovirus that self-inhibits its major late promoter (MLP) to truncate its own replicati...
Autores principales: | Su, Weiheng, Patrício, Maria I., Duffy, Margaret R., Krakowiak, Jakub M., Seymour, Leonard W., Cawood, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901928/ https://www.ncbi.nlm.nih.gov/pubmed/35256603 http://dx.doi.org/10.1038/s41467-022-28738-2 |
Ejemplares similares
-
AdenoBuilder: A platform for the modular assembly of recombinant adenoviruses
por: Jang, Yumi, et al.
Publicado: (2022) -
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
por: Clément, Nathalie, et al.
Publicado: (2016) -
Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome
por: Ayuso, Eduard
Publicado: (2016) -
Use of Tissue-Specific MicroRNA to Control Pathology of Wild-Type Adenovirus without Attenuation of Its Ability to Kill Cancer Cells
por: Cawood, Ryan, et al.
Publicado: (2009) -
MicroRNA Controlled Adenovirus Mediates Anti-Cancer Efficacy without Affecting Endogenous MicroRNA Activity
por: Cawood, Ryan, et al.
Publicado: (2011)